Meet a Company Series welcoming AstraZeneca - Core interests & collaboration opportunities

Meet a Company Series welcoming AstraZeneca - Core interests & collaboration opportunities

21.05.2026 17:15 – 19:00

The School of Pharmaceutical Sciences of the University of Geneva and Unitec, its technology transfer office, present:

AstraZeneca - Core interests & collaboration opportunities
With the kind participation of
Muhammad (Mo) Mustaqim, Director, Transactions, Business Development Operations, AstraZeneca

Join us at this event to hear M. Mustaqim talk about the partnering process with global biopharmaceutical companies, potential areas of collaboration and how to connect and engage with AstraZeneca.

AstraZeneca is a global biopharmaceutical company developing life-changing medicine with therapy areas focusing on oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines and immune therapy, rare diseases, precision medicine and enabling technologies.

The presentation of 45min will be followed by a Q&A session. The event will be in English.

This event is free but registration is mandatory.

Lieu

This event will be online only. Registered participants will receive the zoom link to attend the meeting.

Organisé par

Unitec

Intervenant-e-s

Muhammad (Mo) Mustaqim, Director, Transactions, Business Development Operations, AstraZeneca
Pr Yogeshvar Kalia, Professor, School of Pharmaceutical Sciences, Faculté des Sciences, UNIGE
Dre Jennifer Cadby, Associée aux transferts de technologies, Unitec, UNIGE

entrée libre

Classement

Catégorie: Cours public

Mots clés: Innovation, Collaboration

Plus d'infos

www.unige.ch/unitec/actualite/meet-a-company/meet-company-avec-astrazeneca-21...

Contact: missing email